The first major US airline has changed the rules around portable chargers and batteries — what you need to know
With anxiety of in-flight fires on the rise, airline carriers around the globe are changing policies surrounding portable batteries and chargers.
In the United States, Southwest Airlines is the first of the four biggest American carriers to introduce new restrictions. Starting today (May 29), the airline will require you to have portable chargers visible at all times when using them.
The new policy requires "customers to keep portable charging devices visible while in use during flight," a Southwest spokesperson told Tom's Guide.
"Using portable charging devices while stored in a bag or overhead bin will no longer be permitted," they added.
The spokesperson cited recent fire incidents around the world.
The U.S. carrier is following in the footsteps of airlines from South Korea, Taiwan and Hong Kong which introduced similar policies after a fire destroyed an Air Busan plane in South Korea this past January.
Investigators have blamed a power bank for that fire.
Get instant access to breaking news, the hottest reviews, great deals and helpful tips.
Incidents involving lithium-ion batteries (which make up most portable chargers) on aircraft have been on the rise.
Federal Aviation Agency data cited 89 reports for 2024 and at least 22 through the month of May this year, nearly double from previous years.
Currently, the FAA only requires that lithium-ion devices be kept in carry-on baggage. The European Union has similar rules.
However, policies range between airlines. Southwest lets you keep your battery as long as its visible.
"In the rare event a lithium battery overheats or catches fire, quick access is critical," the Southwest spokesperson said. "Keeping power banks in plain sight allows for faster intervention and helps protect everyone onboard."
By comparison, the low-cost Irish airline, Ryanair requires passengers remove the batteries before storing bags.
After the Air Busan fire, South Korea introduced a law that mandates passengers keep portable chargers within arm's reach and out of bins. Several other Asian airlines introduced similar rules or local governments like Hong Kong have regulations going into place.
Lithium-ion batteries have been banned from cargo holds of passenger plans since 2016, after regulations from the International Aviation Organization of the United Nations were introduced.
The batteries can overheat or expand which can start fires, especially if the battery is damaged or improperly protected..
"Flight crews are trained to recognize and respond to lithium-ion battery fires in the cabin," FAA resources read. "Passengers should notify the flight crew immediately if their lithium-ion battery or portable electronic device is overheating, expanding, smoking, or burning."
Tom's Guide has reached out to the other big airlines (American, Delta and United) to see if they are considering implementing a similar policy. We will update this story if they respond.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
36 minutes ago
- The Hill
Puerto Rico is Trump's perfect partner in reshoring
President Trump recently signed an executive order to bring pharmaceutical manufacturing back to the U.S. by streamlining the process for the Food and Drug Administration to approve pharmaceutical manufacturing plants. This is the latest in the Trump administration's agenda to protect national security and create American jobs by promoting the reshoring of critical supply chains that Americans rely on every day. These efforts are coupled with international tariffs to encourage domestic manufacturing. Reshoring pharmaceutical manufacturing is not only dire for American national security, but it could have resounding economic impacts across the country. One U.S. jurisdiction that is ready and in a perfect position to partner in this effort is Puerto Rico, where pharmaceutical manufacturing is already a more than $50 billion industry. With complementary efforts underway in Congress and on the island, the White House should look to Puerto Rico as America's pharmaceutical powerhouse while not trapping the island in its current territory status by hindering a future transition to statehood that would further boost the island's manufacturing ability. As a territory, the island is part of the U.S. customs zone and is not subject to U.S. tariffs, and everything that is made in Puerto Rico is 'Made in the USA.' Yet, that same territory status has limited Puerto Rico's economic development by creating persistent uncertainty, underinvestment and an unequal playing field for economic competition. The territory status is unpopular on the island, and Puerto Rican voters have voted in favor of statehood four consecutive times, most recently last November. Trump and Congress have the opportunity of a generation to leverage the pharmaceutical infrastructure and workforce in Puerto Rico to achieve their agenda while also turbocharging the economy on the island, and they have the perfect ally in Puerto Rico to do it with — the island's Republican Gov. Jenniffer González-Colón. González-Colón is leading an ambitious agenda to reshape the national narrative about the island and its people — and ultimately achieve statehood for Puerto Rico. Aligning with the Trump administration's vision to reshore advanced manufacturing of critical products, she issued an executive order in late March and reached out to top White House officials to offer Puerto Rico's well-established, yet currently underutilized, manufacturing capacity as an economic engine to help grow American prosperity. González-Colón's executive order promotes the relocation of overseas manufacturing of pharmaceuticals and other products to Puerto Rico. Much like Trump's executive order, it eliminates barriers and streamlines the process for businesses to move to the island. This action is complementary to the Medical Manufacturing, Economic Development and Sustainability Act, which was recently reintroduced and incentivizes pharmaceutical manufacturing on the island and throughout economically distressed zones across the United States. The bill is designed to attract business to the island in a way that invests in the people of Puerto Rico. It does this by providing an incentive for medical manufacturing facilities to relocate to economically distressed zones, with an incentive dependent on the number of jobs created to ensure money is flowing back into communities. The incentive itself is based on economic factors and applies to communities throughout the United States — an appropriately wide scope that comports with Trump's strong desire to reshore large amounts of production in a short time frame. By tethering the tax credits to what manufacturers invest directly into wages, salaries and real middle-class benefits, the proposal creates good-paying, quality American jobs. Reshoring to Puerto Rico would mean that critical pharmaceuticals and medical devices, as well as other products that are currently manufactured overseas in China and other nations, would now be produced in America. This would create thousands of well-paying manufacturing jobs that Puerto Rico needs to turbocharge the modest economic progress it's made in recent years. The increased consumer demand on the island would help boost the approximately $70 billion in annual interstate commerce, resulting in more jobs and profits stateside. Puerto Rico is a natural partner in reshoring the medical and pharmaceutical manufacturing industry within U.S. borders. The island's leaders share in the White House's vision of a more prosperous pharmaceutical manufacturing industry and are working to ensure reshoring efforts do not trap Puerto Rico in its current territory status but instead enable it to reach its full potential as an engine of economic growth and prosperity as a future state of our Union. Manufacturing makes America stronger, especially when it lifts up communities and the hard-working American citizens that make 'Made in the USA' a possibility, including those in Puerto Rico.
Yahoo
an hour ago
- Yahoo
Cooper Companies Second Quarter 2025 Earnings: EPS Misses Expectations
Revenue: US$1.00b (up 6.3% from 2Q 2024). Net income: US$87.7m (down 1.3% from 2Q 2024). Profit margin: 8.7% (down from 9.4% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: US$0.44 (down from US$0.45 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 39%. Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are down 13% from a week ago. While earnings are important, another area to consider is the balance sheet. See our latest analysis on Cooper Companies' balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
2 hours ago
- Yahoo
Blue Origin completes 12th human flight to space
EL PASO, Texas (KTSM) — Space technology company Blue Origin successfully completed its 12th human spaceflight and the 32nd flight for the New Shepard program on Saturday morning, May 31. The launch took place from the company's facility outside of Van Horn and took a human crew to the Karman line, the internationally recognized boundary of space. The crew included: K-12 STEM teacher Aymette Medina Jorge; radiologist turned explorer Dr. Gretchen Green; former Panamanian ambassador to the United States Jaime Alemán; businessman Jesse Williams; aerospace executive Mark Rocket; and entrepreneur Paul Jeris. Including Saturday's crew, New Shepard has now flown 64 people into space — including four who have flown twice — among them scientific researchers, educators, physicians, explorers, and entrepreneurs. 'We thank our customers for trusting us to give them the opportunity to appreciate Earth's fragility from above, an experience that truly transforms those who embark on it,' said Phil Joyce, senior vice president of New Shepard. 'We look forward to seeing what our remarkable crew will do with this experience. I am proud of our team's dedication in making these moments possible.' Here is what Blue Origin said about the New Shepard program: 'Named after astronaut Alan Shepard, the first American in space, New Shepard is Blue Origin's fully reusable, autonomous suborbital rocket system built to fly humans and scientific payloads to space. The rocket is powered by one BE-3PM engine, which is fueled by a highly efficient and clean combination of liquid hydrogen and oxygen. During flight, the only byproduct of New Shepard's engine combustion is water vapor, with no carbon emissions.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
